You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

~ Buy the NATROBA (spinosad) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR NATROBA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for natroba

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01660321 ↗ Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation Completed ParaPRO LLC Phase 4 2011-09-01 A pharmacokinetic and tolerance study of Natroba (spinosad) Topical Suspension, 0.9% in pediatric subjects 6 months to 4 years of age with an active head lice infestation.
NCT02485704 ↗ Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Completed Accelovance Phase 3 2017-05-10 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the complete cure of scabies after a single treatment.
NCT02485704 ↗ Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Completed Concentrics Research Phase 3 2017-05-10 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the complete cure of scabies after a single treatment.
NCT02485704 ↗ Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Completed ParaPRO LLC Phase 3 2017-05-10 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the complete cure of scabies after a single treatment.
NCT02485717 ↗ Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Completed Accelovance Phase 3 2017-05-02 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the pharmacokinetics (PK) of spinosad and benzyl alcohol following a single dose of Natroba™ in pediatric subjects 4-16 years of age. These subjects will be a separate population of pediatric subjects.
NCT02485717 ↗ Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Completed Concentrics Research Phase 3 2017-05-02 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the pharmacokinetics (PK) of spinosad and benzyl alcohol following a single dose of Natroba™ in pediatric subjects 4-16 years of age. These subjects will be a separate population of pediatric subjects.
NCT02485717 ↗ Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Completed ParaPRO LLC Phase 3 2017-05-02 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the pharmacokinetics (PK) of spinosad and benzyl alcohol following a single dose of Natroba™ in pediatric subjects 4-16 years of age. These subjects will be a separate population of pediatric subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for natroba

Condition Name

Condition Name for natroba
Intervention Trials
Scabies 3
Pediculosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for natroba
Intervention Trials
Scabies 3
Parasitic Diseases 1
Lice Infestations 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for natroba

Trials by Country

Trials by Country for natroba
Location Trials
United States 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for natroba
Location Trials
Florida 4
California 3
Pennsylvania 2
Mississippi 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for natroba

Clinical Trial Phase

Clinical Trial Phase for natroba
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for natroba
Clinical Trial Phase Trials
Completed 3
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for natroba

Sponsor Name

Sponsor Name for natroba
Sponsor Trials
ParaPRO LLC 4
Concentrics Research 3
Accelovance 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for natroba
Sponsor Trials
Industry 7
Other 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.